Facebook Stock Climbs as Investors Ignore Congressional Hearings (NASDAQ: FB)

Wallstreet investors seems to be ignoring the hearings in DC on Facebook as CEO Mark Zuckerburg took a beating from both Republicans and Democrats this week at hearings.  Facebook shares are trading at a discount of 2.1% to a monthly maximum, reflecting an uptrend since early October. Since the beginning of the year, the emitter’s quotes strengthened by 28%. On October 30, after the market closes, the company will report for Q3 2019. The Wall Street expects another strong quarter, with revenue up by 26% (YoY) to USD 17.3 billion and net earnings per share up by 8% (YoY) to USD$ 1.9.

fb facebook stock chart
fb facebook stock chart

During the previous week, Facebook shares dropped by 2.11%. S&P500 went up by 0.40% within the same period.

Support and resistance

The emitter is trading within the flat market. The technical picture is uncertain. At the moment, the following key levels of support and resistance can be distinguished: at 183.00 and 191.000, respectively. #FB shares have the potential for decline.

stock newsAD - Recover your investment losses! Haselkorn & Thibaut, P.A. is a national law firm that specializes in fighting ONLY on behalf of investors. With a 95% success rate, let us help you recover your investment losses today. Call now 1 888-628-5590 or visit InvestmentFraudLawyers.com to schedule a free consultation and learn how our experience can help you recover your investment losses. No recovery, no fee.

Indicators don’t give a clear signal: the price has crossed MA(50) and MA(200), and MACD histogram is approaching zero line. Positions are to be opened from key levels.

Comparing the company’s multiplier with its competitors, we can say that #FB shares are neutral.

Support levels: 183.00, 173.00, 164.00.

abs-adviso-reportr

Resistance levels: 191.00, 198.00, 207.00.

Trading tips

If the price consolidates below the support level of 183.00, #FB quotes may decline. Potential profits should be locked in by orders at 178.00, 174.00, and 170.00. Stop loss – 188.00.

If the price consolidates above the level of 191.00, one may consider buying #FB. The moving potential is aimed at the area of 200.00–205.00. Stop loss – 186.00.

ABS REPORT

Implementation period: 3 days.

Facebook, Inc. provides various products to connect and share through mobile devices, personal computers, and other surfaces worldwide. The company’s products include Facebook that enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers; Instagram, a community for sharing photos, videos, and messages; Messenger, a messaging application for people to connect with friends, family, groups, and businesses across platforms and devices; and WhatsApp, a messaging application for use by people and businesses to communicate in a private way. It also provides Oculus, a hardware, software, and developer ecosystem, which allows people to come together and connect with each other through its Oculus virtual reality products. As of December 31, 2018, it had approximately 1.52 billion daily active users. The company was founded in 2004 and is headquartered in Menlo Park, California.

Aug-02-19 Resumed MKM Partners Buy $190 → $245
Jul-25-19 Reiterated Pivotal Research Group Buy $220 → $225
Jul-25-19 Reiterated Monness Crespi & Hardt Buy $250 → $260
Jun-27-19 Reiterated Deutsche Bank Buy $220 → $230
Jun-11-19 Upgrade MoffettNathanson Neutral → Buy $210
May-29-19 Initiated Pivotal Research Group Buy
Apr-25-19 Upgrade UBS Neutral → Buy $170 → $240
Apr-25-19 Reiterated Monness Crespi & Hardt Buy $225 → $250
Apr-04-19 Upgrade Guggenheim Neutral → Buy $175 → $200
Mar-18-19 Downgrade Needham Buy → Hold
Mar-11-19 Upgrade Nomura Neutral → Buy $172 → $215
Jan-31-19 Reiterated UBS Neutral $160 → $170
Jan-31-19 Reiterated Rosenblatt Buy $206 → $212
Jan-31-19 Reiterated RBC Capital Mkts Outperform $190 → $200
Jan-31-19 Reiterated Raymond James Outperform $180 → $200
Jan-31-19 Reiterated Pivotal Research Group Sell $113 → $120
Jan-31-19 Reiterated Oppenheimer Outperform $185 → $195
Jan-31-19 Reiterated Nomura Neutral $148 → $172
Jan-31-19 Reiterated Morgan Stanley Overweight $175 → $190
Jan-31-19 Reiterated Mizuho Buy $200 → $210
Don't miss a thing

Get free professional market insights and stock/ETF reports that contain actionable opportunities written by a former financial advisor and Capitalist who has been investing in the markets for 20+ years.

Scroll to Top